4
Changes in Ownership
Inhibitor Therapeutics, Inc. Filed Acc 0001144204-16-132226
10% owner acquired 38,833,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mayne Pharma Ventures Pty Ltd 10% owner | 2016-11-04 | Option exercise | +5,500,000 | 154,562,230 | D: show line 1 in the form | ||
| Mayne Pharma Ventures Pty Ltd 10% owner | 2016-11-04 | Option exercise | +33,333,000 | 187,895,230 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Mayne Pharma Ventures Pty Ltd 10% owner | 2016-11-04 | Option exercise · Warrant to Purchase Common Stock | −5,500,000 | 4,750,569 | D: show line 3 in the form | |||||
| Mayne Pharma Ventures Pty Ltd 10% owner | 2016-11-04 | Option exercise · Warrant to Purchase Common Stock | −33,333,000 | 333 | D: show line 4 in the form |
Loading xslF345X03/v452354_4.xml…